Aligos Therapeutics
Earnings Surprise
Analysts estimated ALGS earnings of $-1.94 per share this quarter (Q3). ALGS's actual earnings were $-3.04 per share.
ALGS EPS surprise of -56.86%Analysts estimated ALGS earnings of $-2.41 per share this quarter (Q2). ALGS's actual earnings were $-1.53 per share.
ALGS EPS surprise of 36.53%Analysts estimated ALGS earnings of $-2.85 per share this quarter (Q1). ALGS's actual earnings were $-2.11 per share.
ALGS EPS surprise of 26.03%Analysts estimated ALGS earnings of $-2.55 per share this quarter (Q4). ALGS's actual earnings were $-3.40 per share.
ALGS EPS surprise of -33.51%Analysts estimated ALGS earnings of $-2.20 per share this quarter (Q3). ALGS's actual earnings were $-3.07 per share.
ALGS EPS surprise of -39.56%Analysts estimated ALGS earnings of $-4.08 per share this quarter (Q2). ALGS's actual earnings were $0.80 per share.
ALGS EPS surprise of 119.61%Analysts estimated ALGS earnings of $-0.19 per share this quarter (Q1). ALGS's actual earnings were $-0.22 per share.
ALGS EPS surprise of -13.52%Analysts estimated ALGS earnings of $-0.28 per share this quarter (Q4). ALGS's actual earnings were $-0.22 per share.
ALGS EPS surprise of -20.12%Analysts estimated ALGS earnings of $-0.48 per share this quarter (Q3). ALGS's actual earnings were $-0.41 per share.
ALGS EPS surprise of -15.38%